ArticleCureus2024
Possible Link Between Tamoxifen and Suicidality: A Case Report Analysis of a 43-Year-Old Woman With Mood Disorder and Breast Cancer.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tamoxifen, a selective estrogen receptor modulator (SERM), has long been a cornerstone in the treatment of hormone receptor-positive breast cancer. While its benefits in reducing the risk of recurrence and mortality in this patient population are well-established, emerging evidence suggests a potential association between tamoxifen use and adverse psychiatric effects, including suicidality. Despite extensive research on the clinical efficacy of tamoxifen, the exploration of its psychiatric side effects, including suicidality, remains relatively understudied. We present a case of a woman with a medical history of depression and invasive lobular carcinoma of the left breast who developed a severe episode of recurrent major depressive disorder (MDD) and attempted suicide with a benzodiazepine overdose upon initiating tamoxifen for her breast cancer. This case report aims to contribute to the growing body of literature on the relationship between tamoxifen and suicidality by presenting a detailed analysis of a patient who experienced suicidality while undergoing tamoxifen therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.